Prednisone-Treated Duchenne Muscular Dystrophy

Abstract

The immunosuppressant/antiinflammatory effects of prednisone were studied in 33 patients with Duchenne muscular dystrophy (ages 5 to 15 years) at the conclusion of a six month treatment trial at the Department of Neurology, Division of Neuromuscular Disease, Ohio State University College of Medicine, Columbus, OH.

Keywords

• duchenne muscular dystrophy
• low-dose prednisone group
• immunologic mechanisms